Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CELEB: Allogeneic hMSCs in Non-CF Bronchiectasis
NCT02625246Phase 1Completed
- Start
- Feb 2016
- Primary completion
- May 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of MSV alogénicas in Non-cystic fibrosis bronchiectasis (NCFB) (2 arms). Primary endpoint: Number of Participant with treatment emergent serious adverse events. Started Feb 2016; status: completed.
02
Drugs
MSV alogénicas
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT02625246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02625246.